Percutaneous intervention in patients with cancer: can we offer an improvement in safety?

Iñigo Lozano^{1

2}, Jose Miguel Vegas¹, Juan Rondan¹

Affiliations

¹ Department of Cardiology, Hospital de Cabueñes, Avda. Los Prados, 395, Gijón 33203, Spain.
² EPIC Foundation, Pº Condesa de Sagasta 10, 1ºC, León 24001, Spain.

Comment

Iñigo Lozano et al. Eur Heart J. 2021.

. 2021 Dec 21;42(48):4981.

doi: 10.1093/eurheartj/ehab401.

Iñigo Lozano^{1

2}, Jose Miguel Vegas¹, Juan Rondan¹

¹ Department of Cardiology, Hospital de Cabueñes, Avda. Los Prados, 395, Gijón 33203, Spain.
² EPIC Foundation, Pº Condesa de Sagasta 10, 1ºC, León 24001, Spain.

No abstract available

Comment in

Decision making in percutaneous coronary intervention in patients with cancer: balancing ischaemic and bleeding risk.
Mamas MA. Mamas MA. Eur Heart J. 2021 Dec 21;42(48):4982-4983. doi: 10.1093/eurheartj/ehab403. Eur Heart J. 2021. PMID: 34254123 No abstract available.

Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
Kwok CS, Wong CW, Kontopantelis E, Barac A, Brown SA, Velagapudi P, Hilliard AA, Bharadwaj AS, Chadi Alraies M, Mohamed M, Bhatt DL, Mamas MA. Kwok CS, et al. Eur Heart J. 2021 Mar 7;42(10):1019-1034. doi: 10.1093/eurheartj/ehaa1032. Eur Heart J. 2021. PMID: 33681960
Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
Marenzi G, Cosentino N, Cardinale D. Marenzi G, et al. Eur Heart J. 2021 Mar 7;42(10):1035-1037. doi: 10.1093/eurheartj/ehaa1109. Eur Heart J. 2021. PMID: 33681982 No abstract available.